{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:10:57Z","timestamp":1787508657143,"version":"build-2736575974"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31870726"],"award-info":[{"award-number":["31870726"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31970880"],"award-info":[{"award-number":["31970880"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31870153"],"award-info":[{"award-number":["31870153"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Strategic Priority Research Program of CAS","award":["XDB37020204"],"award-info":[{"award-number":["XDB37020204"]}]},{"name":"Strategic Priority Research Program of CAS","award":["XDB29010102"],"award-info":[{"award-number":["XDB29010102"]}]},{"name":"Key Program of CAS Frontier Science","award":["QYZDB\u2010SSW\u2010SMC037"],"award-info":[{"award-number":["QYZDB\u2010SSW\u2010SMC037"]}]},{"name":"Ministry of Science and Technology of China","award":["2020YFC0845900"],"award-info":[{"award-number":["2020YFC0845900"]}]},{"name":"Ministry of Science and Technology of China","award":["2017YFA0506700"],"award-info":[{"award-number":["2017YFA0506700"]}]},{"name":"CAS President's International Fellowship Initiative","award":["2020VBA0023"],"award-info":[{"award-number":["2020VBA0023"]}]},{"name":"The Key R&D Program of Jiangsu Province (Social Development) Project","award":["BE2019625"],"award-info":[{"award-number":["BE2019625"]}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["20ZR1466700"],"award-info":[{"award-number":["20ZR1466700"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["20490760200"],"award-info":[{"award-number":["20490760200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Municipal Science and Technology Major Project","award":["20431900402"],"award-info":[{"award-number":["20431900402"]}]},{"name":"Innovation Capacity Building Project of Jiangsu province Nanjing Unicorn Academy of innovation","award":["BM2020019"],"award-info":[{"award-number":["BM2020019"]}]},{"name":"European Union's Horizon 2020 Research & Innovation program","award":["824061"],"award-info":[{"award-number":["824061"]}]},{"name":"Science and Technology Commission of Hangzhou Municipality","award":["202013A02"],"award-info":[{"award-number":["202013A02"]}]},{"name":"RECOVER European Union's Horizon 2020 research and innovation program","award":["101003589"],"award-info":[{"award-number":["101003589"]}]},{"name":"NSFC Outstanding Young Scholars","award":["31822055"],"award-info":[{"award-number":["31822055"]}]},{"DOI":"10.13039\/501100004739","name":"Youth Innovation Promotion Association of the Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2017122"],"award-info":[{"award-number":["2017122"]}],"id":[{"id":"10.13039\/501100004739","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CAS Grant","award":["JCTD\u20102020\u201017"],"award-info":[{"award-number":["JCTD\u20102020\u201017"]}]},{"name":"CAS Facility\u2010based Open Research Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2021,12,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    An essential step for SARS\u2010CoV\u20102 infection is the attachment to the host cell receptor by its Spike receptor\u2010binding domain (RBD). Most of the existing RBD\u2010targeting neutralizing antibodies block the receptor\u2010binding motif (RBM), a mutable region with the potential to generate neutralization escape mutants. Here, we isolated and structurally characterized a non\u2010RBM\u2010targeting monoclonal antibody (FD20) from convalescent patients. FD20 engages the RBD at an epitope distal to the RBM with a\n                    <jats:italic>K<\/jats:italic>\n                    <jats:sub>D<\/jats:sub>\n                    of 5.6\u2009nM, neutralizes SARS\u2010CoV\u20102 including the current Variants of Concern such as B.1.1.7, B.1.351, P.1, and B.1.617.2 (Delta), displays modest cross\u2010reactivity against SARS\u2010CoV, and reduces viral replication in hamsters. The epitope coincides with a predicted \u201cideal\u201d vulnerability site with high functional and structural constraints. Mutation of the residues of the conserved epitope variably affects FD20\u2010binding but confers little or no resistance to neutralization. Finally,\n                    <jats:italic>in\u2009vitro<\/jats:italic>\n                    mode\u2010of\u2010action characterization and negative\u2010stain electron microscopy suggest a neutralization mechanism by which FD20 destructs the Spike. Our results reveal a conserved vulnerability site in the SARS\u2010CoV\u20102 Spike for the development of potential antiviral drugs.\n                  <\/jats:p>","DOI":"10.15252\/emmm.202114544","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T10:12:36Z","timestamp":1634811156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Uncovering a conserved vulnerability site in SARS\u2010CoV\u20102 by a human antibody"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3146-2761","authenticated-orcid":false,"given":"Tingting","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7738-6181","authenticated-orcid":false,"given":"Yapei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8588-5877","authenticated-orcid":false,"given":"Hebang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu Daisy","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2213-5910","authenticated-orcid":false,"given":"Martje Fentener","family":"van Vlissingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thijs","family":"Kuiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corine H","family":"GeurtsvanKessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhuan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moumita","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0345-2814","authenticated-orcid":false,"given":"Shiqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey S","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Raoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JianFeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haisheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2161-1359","authenticated-orcid":false,"given":"Zhong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuechao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhai","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Rockx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0945-962X","authenticated-orcid":false,"given":"Junfang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0333-6872","authenticated-orcid":false,"given":"Fei\u2010Long","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4706-1519","authenticated-orcid":false,"given":"Dimitri","family":"Lavillette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4729-4678","authenticated-orcid":false,"given":"Dianfan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"key":"BFEMMM202114544_CR1","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4049\/jimmunol.2000583","volume":"205","author":"WB Alsoussi","year":"2020","unstructured":"Alsoussi WB, Turner JS, Case JB, Zhao H, Schmitz AJ, Zhou JQ, Chen RE, Lei T, Rizk AA, McIntire KM et\u2009al (2020) A potently neutralizing antibody protects mice against SARS\u2010CoV\u20102 infection. J Immunol 205: 915\u2013922","journal-title":"J Immunol"},{"key":"BFEMMM202114544_CR2","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.cell.2020.06.025","volume":"182","author":"CO Barnes","year":"2020","unstructured":"Barnes CO, West Jr AP, Huey\u2010Tubman KE, Hoffmann MAG, Sharaf NG, Hoffman PR, Koranda N, Gristick HB, Gaebler C, Muecksch F et\u2009al (2020) Structures of human antibodies bound to SARS\u2010CoV\u20102 spike reveal common epitopes and recurrent features of antibodies. Cell 182: 828\u2013842","journal-title":"Cell"},{"key":"BFEMMM202114544_CR3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.abc5902","volume":"369","author":"PJM Brouwer","year":"2020","unstructured":"Brouwer PJM, Caniels TG, van der Straten K, Snitselaar JL, Aldon Y, Bangaru S, Torres JL, Okba NMA, Claireaux M, Kerster G et\u2009al (2020) Potent neutralizing antibodies from COVID\u201019 patients define multiple targets of vulnerability. Science 369: 643\u2013650","journal-title":"Science"},{"key":"BFEMMM202114544_CR4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","volume":"182","author":"Y Cao","year":"2020","unstructured":"Cao Y, Su B, Guo X, Sun W, Deng Y, Bao L, Zhu Q, Zhang X, Zheng Y, Geng C et\u2009al (2020) Potent neutralizing antibodies against SARS\u2010CoV\u20102 identified by high\u2010throughput single\u2010cell sequencing of convalescent patients\u2019 B cells. Cell 182: 73\u201384","journal-title":"Cell"},{"key":"BFEMMM202114544_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1203\/01.PDR.0000129184.87042.FC","volume":"56","author":"JD Cherry","year":"2004","unstructured":"Cherry JD, Krogstad P (2004) SARS: the first pandemic of the 21st century. Pediatr Res 56: 1\u20135","journal-title":"Pediatr Res"},{"key":"BFEMMM202114544_CR6","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1126\/science.abc6952","volume":"369","author":"X Chi","year":"2020","unstructured":"Chi X, Yan R, Zhang J, Zhang G, Zhang Y, Hao M, Zhang Z, Fan P, Dong Y, Yang Y et\u2009al (2020) A potent neutralizing human antibody reveals the N\u2010terminal domain of the Spike protein of SARS\u2010CoV\u20102 as a site of vulnerability. Science 369: 650\u2013655","journal-title":"Science"},{"key":"BFEMMM202114544_CR7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41586-021-03412-7","volume":"593","author":"DA Collier","year":"2021","unstructured":"Collier DA, De Marco A, Ferreira IATM, Meng B, Datir R, Walls AC, Kemp SSA, Bassi J, Pinto D, Fregni CS et\u2009al (2021) Sensitivity of SARS\u2010CoV\u20102 B.1.1.7 to mRNA vaccine\u2010elicited antibodies. Nature 593: 136\u2013141","journal-title":"Nature"},{"key":"BFEMMM202114544_CR8","first-page":"2000045","volume":"25","author":"VM Corman","year":"2020","unstructured":"Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T, Br\u00fcnink S, Schneider J, Schmidt ML et\u2009al (2020) Detection of 2019 novel coronavirus (2019\u2010nCoV) by real\u2010time RT\u2010PCR. Euro Surveill 25: 2000045","journal-title":"Euro Surveill"},{"key":"BFEMMM202114544_CR9","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.cell.2020.06.035","volume":"182","author":"L Dai","year":"2020","unstructured":"Dai L, Zheng T, Xu K, Han Y, Xu L, Huang E, An Y, Cheng Y, Li S, Liu M et\u2009al (2020) A universal design of betacoronavirus vaccines against COVID\u201019, MERS, and SARS. Cell 182: 722\u2013733","journal-title":"Cell"},{"key":"BFEMMM202114544_CR10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/gch2.1018","volume":"1","author":"S Elbe","year":"2017","unstructured":"Elbe S, Buckland\u2010Merrett G (2017) Data, disease and diplomacy: GISAID's innovative contribution to global health. Glob Chall 1: 33\u201346","journal-title":"Glob Chall"},{"key":"BFEMMM202114544_CR11","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta Crystallogr D 66: 486\u2013501","journal-title":"Acta Crystallogr D"},{"key":"BFEMMM202114544_CR12","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1107\/S0907444913000061","volume":"69","author":"PR Evans","year":"2013","unstructured":"Evans PR, Murshudov GN (2013) How good are my data and what is the resolution? Acta Crystallgr D 69: 1204\u20131214","journal-title":"Acta Crystallgr D"},{"key":"BFEMMM202114544_CR13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/bs.mie.2016.05.005","volume":"580","author":"JC Frei","year":"2016","unstructured":"Frei JC, Lai JR (2016) Protein and antibody engineering by phage display. Methods Enzymol 580: 45\u201387","journal-title":"Methods Enzymol"},{"key":"BFEMMM202114544_CR14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12250-016-3713-9","volume":"31","author":"X\u2010Y Ge","year":"2016","unstructured":"Ge X\u2010Y, Wang N, Zhang W, Hu B, Li B, Zhang Y\u2010Z, Zhou J\u2010H, Luo C\u2010M, Yang X\u2010L, Wu L\u2010J et\u2009al (2016) Coexistence of multiple coronaviruses in several bat colonies in an abandoned mineshaft. Virol Sin 31: 31\u201340","journal-title":"Virol Sin"},{"key":"BFEMMM202114544_CR15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.chom.2020.11.007","volume":"29","author":"AJ Greaney","year":"2020","unstructured":"Greaney AJ, Starr TN, Gilchuk P, Zost SJ, Binshtein E, Loes AN, Hilton SK, Huddleston J, Eguia R, Crawford KH et\u2009al (2020) Complete mapping of mutations to the SARS\u2010CoV\u20102 spike receptor\u2010binding domain that escape antibody recognition. Cell Host Microbe 29, 44\u201357","journal-title":"Cell Host Microbe"},{"key":"BFEMMM202114544_CR16","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.abd0827","volume":"369","author":"J Hansen","year":"2020","unstructured":"Hansen J, Baum A, Pascal KE, Russo V, Giordano S, Wloga E, Fulton BO, Yan Y, Koon K, Patel K et\u2009al (2020) Studies in humanized mice and convalescent humans yield a SARS\u2010CoV\u20102 antibody cocktail. Science 369: 1010\u20131014","journal-title":"Science"},{"key":"BFEMMM202114544_CR17","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.abd0826","volume":"369","author":"C\u2010L Hsieh","year":"2020","unstructured":"Hsieh C\u2010L, Goldsmith JA, Schaub JM, DiVenere AM, Kuo H\u2010C, Javanmardi K, Le KC, Wrapp D, Lee AG, Liu Y et\u2009al (2020) Structure\u2010based design of prefusion\u2010stabilized SARS\u2010CoV\u20102 spikes. Science 369: 1501\u20131505","journal-title":"Science"},{"key":"BFEMMM202114544_CR18","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41594-020-0469-6","volume":"27","author":"J Huo","year":"2020","unstructured":"Huo J, Le Bas A, Ruza RR, Duyvesteyn HME, Mikolajek H, Malinauskas T, Tan TK, Rijal P, Dumoux M, Ward PN et\u2009al (2020) Neutralizing nanobodies bind SARS\u2010CoV\u20102 spike RBD and block interaction with ACE2. Nat Struct Mol Biol 27: 846\u2013854","journal-title":"Nat Struct Mol Biol"},{"key":"BFEMMM202114544_CR19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.chom.2020.06.010","volume":"28","author":"J Huo","year":"2020","unstructured":"Huo J, Zhao Y, Ren J, Zhou D, Duyvesteyn HME, Ginn HM, Carrique L, Malinauskas T, Ruza RR, Shah PNM et\u2009al (2020) Neutralization of SARS\u2010CoV\u20102 by destruction of the prefusion spike. Cell Host Microbe 28: 445\u2013454.e6","journal-title":"Cell Host Microbe"},{"key":"BFEMMM202114544_CR20","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1038\/s41467-020-19231-9","volume":"11","author":"NK Hurlburt","year":"2020","unstructured":"Hurlburt NK, Seydoux E, Wan YH, Edara VV, Stuart AB, Feng J, Suthar MS, McGuire AT, Stamatatos L, Pancera M (2020) Structural basis for potent neutralization of SARS\u2010CoV\u20102 and role of antibody affinity maturation. Nat Commun 11: 5413","journal-title":"Nat Commun"},{"key":"BFEMMM202114544_CR21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","volume":"584","author":"B Ju","year":"2020","unstructured":"Ju B, Zhang Q, Ge J, Wang R, Sun J, Ge X, Yu J, Shan S, Zhou B, Song S et\u2009al (2020) Human neutralizing antibodies elicited by SARS\u2010CoV\u20102 infection. Nature 584: 115\u2013119","journal-title":"Nature"},{"key":"BFEMMM202114544_CR22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch W (2010) XDS. Acta Crystallogr D 66: 125\u2013132","journal-title":"Acta Crystallogr D"},{"key":"BFEMMM202114544_CR23","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","volume":"182","author":"B Korber","year":"2020","unstructured":"Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, Hengartner N, Giorgi EE, Bhattacharya T, Foley B et\u2009al (2020) Tracking changes in SARS\u2010CoV\u20102 spike: evidence that D614G increases infectivity of the COVID\u201019 virus. Cell 182: 812\u2013827","journal-title":"Cell"},{"key":"BFEMMM202114544_CR24","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","volume":"372","author":"E Krissinel","year":"2007","unstructured":"Krissinel E, Henrick K (2007) Inference of macromolecular assemblies from crystalline state. J Mol Biol 372: 774\u2013797","journal-title":"J Mol Biol"},{"key":"BFEMMM202114544_CR25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, Zhang Q, Shi X, Wang Q, Zhang L et\u2009al (2020) Structure of the SARS\u2010CoV\u20102 spike receptor\u2010binding domain bound to the ACE2 receptor. Nature 581: 215\u2013220","journal-title":"Nature"},{"key":"BFEMMM202114544_CR26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009500","volume":"17","author":"M Laporte","year":"2021","unstructured":"Laporte M, Raeymaekers V, Van Berwaer R, Vandeput J, Marchand\u2010Casas I, Thibaut H\u2010J, Van Looveren D, Martens K, Hoffmann M, Maes P et\u2009al (2021) The SARS\u2010CoV\u20102 and other human coronavirus spike proteins are fine\u2010tuned towards temperature and proteases of the human airways. PLoS Pathog 17: e1009500","journal-title":"PLoS Pathog"},{"key":"BFEMMM202114544_CR27","doi-asserted-by":"crossref","first-page":"2100009","DOI":"10.2807\/1560-7917.ES.2021.26.5.210009","volume":"26","author":"HD Larsen","year":"2021","unstructured":"Larsen HD, Fonager J, Lomholt FK, Dalby T, Benedetti G, Kristensen B, Urth TR, Rasmussen M, Lassauni\u00e8re R, Rasmussen TB et\u2009al (2021) Preliminary report of an outbreak of SARS\u2010CoV\u20102 in mink and mink farmers associated with community spread, Denmark, June to November 2020. Euro Surveill 26: 2100009","journal-title":"Euro Surveill"},{"key":"BFEMMM202114544_CR28","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-208849\/v1","author":"P Lemey","year":"2021","unstructured":"Lemey P, Ruktanonchai N, Hong S, Colizza V, Poletto C, den Broeck FV, Gill M, Ji X, Levasseur A, Sadilek A et\u2009al (2021) SARS\u2010CoV\u20102 European resurgence foretold: interplay of introductions and persistence by leveraging genomic and mobility data. Res Sq https:\/\/doi.org\/10.21203\/rs.3.rs\u2010208849\/v1 [PREPRINT]","journal-title":"Res Sq"},{"key":"BFEMMM202114544_CR29","first-page":"2002106","volume":"26","author":"K Leung","year":"2021","unstructured":"Leung K, Shum MH, Leung GM, Lam TT, Wu JT (2021) Early transmissibility assessment of the N501Y mutant strains of SARS\u2010CoV\u20102 in the United Kingdom, October to November 2020. Euro Surveill 26: 2002106","journal-title":"Euro Surveill"},{"key":"BFEMMM202114544_CR30","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2020.07.012","volume":"182","author":"Q Li","year":"2020","unstructured":"Li Q, Wu J, Nie J, Zhang L, Hao H, Liu S, Zhao C, Zhang Q, Liu H, Nie L et\u2009al (2020) The impact of mutations in SARS\u2010CoV\u20102 spike on viral infectivity and antigenicity. Cell 182: 1284\u20131294","journal-title":"Cell"},{"key":"BFEMMM202114544_CR31","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1038\/s41467-021-24905-z","volume":"12","author":"T Li","year":"2021","unstructured":"Li T, Cai H, Yao H, Zhou B, Zhang N, van Vlissingen MF, Kuiken T, Han W, GeurtsvanKessel CH, Gong Y et\u2009al (2021) A synthetic nanobody targeting RBD protects hamsters from SARS\u2010CoV\u20102 infection. Nat Commun 12: 4635","journal-title":"Nat Commun"},{"key":"BFEMMM202114544_CR32","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.immuni.2020.10.023","volume":"53","author":"H Liu","year":"2020","unstructured":"Liu H, Wu NC, Yuan M, Bangaru S, Torres JL, Caniels TG, van Schooten J, Zhu X, Lee C\u2010C, Brouwer PJM et\u2009al (2020) Cross\u2010neutralization of a SARS\u2010CoV\u20102 antibody to a functionally conserved site is mediated by avidity. Immunity 53: 1272\u20131280","journal-title":"Immunity"},{"key":"BFEMMM202114544_CR33","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.celrep.2018.09.090","volume":"25","author":"LD Liu","year":"2018","unstructured":"Liu LD, Huang M, Dai P, Liu T, Fan S, Cheng X, Zhao Y, Yeap LS, Meng FL (2018) Intrinsic nucleotide preference of diversifying base editors guides antibody ex\u2009vivo affinity maturation. Cell Rep 25: 884\u2013892","journal-title":"Cell Rep"},{"key":"BFEMMM202114544_CR34","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-020-2571-7","volume":"584","author":"L Liu","year":"2020","unstructured":"Liu L, Wang P, Nair MS, Yu J, Rapp M, Wang Q, Luo Y, Chan J\u2010W, Sahi V, Figueroa A et\u2009al (2020) Potent neutralizing antibodies against multiple epitopes on SARS\u2010CoV\u20102 spike. Nature 584: 450\u2013456","journal-title":"Nature"},{"key":"BFEMMM202114544_CR35","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMoa2108891","volume":"385","author":"J Lopez Bernal","year":"2021","unstructured":"Lopez Bernal J, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, Stowe J, Tessier E, Groves N, Dabrera G et\u2009al (2021) Effectiveness of Covid\u201019 vaccines against the B.1.617.2 (Delta) variant. N Engl J Med 385: 585\u2013594","journal-title":"N Engl J Med"},{"key":"BFEMMM202114544_CR36","doi-asserted-by":"crossref","first-page":"107725","DOI":"10.1016\/j.celrep.2020.107725","volume":"31","author":"H Lv","year":"2020","unstructured":"Lv H, Wu NC, Tsang O\u2010Y, Yuan M, Perera RAPM, Leung WS, So RTY, Chan JMC, Yip GK, Chik TSH et\u2009al (2020) Cross\u2010reactive antibody response between SARS\u2010CoV\u20102 and SARS\u2010CoV infections. Cell Rep 31: 107725","journal-title":"Cell Rep"},{"key":"BFEMMM202114544_CR37","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1126\/science.abc5881","volume":"369","author":"Z Lv","year":"2020","unstructured":"Lv Z, Deng Y\u2010Q, Ye Q, Cao L, Sun C\u2010Y, Fan C, Huang W, Sun S, Sun Y, Zhu L et\u2009al (2020) Structural basis for neutralization of SARS\u2010CoV\u20102 and SARS\u2010CoV by a potent therapeutic antibody. Science 369: 1505\u20131509","journal-title":"Science"},{"key":"BFEMMM202114544_CR38","doi-asserted-by":"crossref","first-page":"26570","DOI":"10.1074\/jbc.M110.112284","volume":"285","author":"HR Maun","year":"2010","unstructured":"Maun HR, Wen X, Lingel A, de Sauvage FJ, Lazarus RA, Scales SJ, Hymowitz SG (2010) Hedgehog pathway antagonist 5E1 binds hedgehog at the pseudo\u2010active site. J Biol Chem 285: 26570\u201326580","journal-title":"J Biol Chem"},{"key":"BFEMMM202114544_CR39","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.cell.2021.03.028","volume":"184","author":"M McCallum","year":"2021","unstructured":"McCallum M, De Marco A, Lempp FA, Tortorici MA, Pinto D, Walls AC, Beltramello M, Chen A, Liu Z, Zatta F et\u2009al (2021) N\u2010terminal domain antigenic mapping reveals a site of vulnerability for SARS\u2010CoV\u20102. Cell 184: 2332\u20132347","journal-title":"Cell"},{"key":"BFEMMM202114544_CR40","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy AJ, Grosse\u2010Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ (2007) Phaser crystallographic software. J Appl Crystallogr 40: 658\u2013674","journal-title":"J Appl Crystallogr"},{"key":"BFEMMM202114544_CR41","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3201\/eid2607.200841","volume":"26","author":"NMA Okba","year":"2020","unstructured":"Okba NMA, M\u00fcller MA, Li W, Wang C, GeurtsvanKessel CH, Corman VM, Lamers MM, Sikkema RS, de Bruin E, Chandler FD et\u2009al (2020) Severe acute respiratory syndrome coronavirus 2\u2010specific antibody responses in coronavirus disease patients. Emerg Infect Dis 26: 1478\u20131488","journal-title":"Emerg Infect Dis"},{"key":"BFEMMM202114544_CR42","doi-asserted-by":"crossref","first-page":"15216","DOI":"10.1038\/ncomms15216","volume":"8","author":"X Ou","year":"2017","unstructured":"Ou X, Guan H, Qin B, Mu Z, Wojdyla JA, Wang M, Dominguez SR, Qian Z, Cui S (2017) Crystal structure of the receptor binding domain of the spike glycoprotein of human betacoronavirus HKU1. Nat Commun 8: 15216","journal-title":"Nat Commun"},{"key":"BFEMMM202114544_CR43","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","volume":"11","author":"X Ou","year":"2020","unstructured":"Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, Guo L, Guo R, Chen T, Hu J et\u2009al (2020) Characterization of spike glycoprotein of SARS\u2010CoV\u20102 on virus entry and its immune cross\u2010reactivity with SARS\u2010CoV. Nat Commun 11: 1620","journal-title":"Nat Commun"},{"key":"BFEMMM202114544_CR44","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1126\/science.abe5901","volume":"371","author":"BB Oude Munnink","year":"2021","unstructured":"Oude Munnink BB, Sikkema RS, Nieuwenhuijse DF, Molenaar RJ, Munger E, Molenkamp R, van der Spek A, Tolsma P, Rietveld A, Brouwer M et\u2009al (2021) Transmission of SARS\u2010CoV\u20102 on mink farms between humans and mink and back to humans. Science 371: 172\u2013177","journal-title":"Science"},{"key":"BFEMMM202114544_CR45","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","volume":"183","author":"L Piccoli","year":"2020","unstructured":"Piccoli L, Park YJ, Tortorici MA, Czudnochowski N, Walls AC, Beltramello M, Silacci\u2010Fregni C, Pinto D, Rosen LE, Bowen JE et\u2009al (2020) Mapping neutralizing and immunodominant sites on the SARS\u2010CoV\u20102 spike receptor\u2010binding domain by structure\u2010guided high\u2010resolution serology. Cell 183: 1024\u20131042","journal-title":"Cell"},{"key":"BFEMMM202114544_CR46","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","volume":"583","author":"D Pinto","year":"2020","unstructured":"Pinto D, Park Y\u2010J, Beltramello M, Walls AC, Tortorici MA, Bianchi S, Jaconi S, Culap K, Zatta F, De Marco A et\u2009al (2020) Cross\u2010neutralization of SARS\u2010CoV\u20102 by a human monoclonal SARS\u2010CoV antibody. Nature 583: 290\u2013295","journal-title":"Nature"},{"key":"BFEMMM202114544_CR47","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1126\/science.abj3321","volume":"373","author":"D Pinto","year":"2021","unstructured":"Pinto D, Sauer MM, Czudnochowski N, Low JS, Tortorici MA, Housley MP, Noack J, Walls AC, Bowen JE, Guarino B et\u2009al (2021) Broad betacoronavirus neutralization by a stem helix\u2013specific human antibody. Science 373: 1109\u20131116","journal-title":"Science"},{"key":"BFEMMM202114544_CR48","doi-asserted-by":"crossref","first-page":"15829","DOI":"10.1074\/jbc.M600697200","volume":"281","author":"P Prabakaran","year":"2006","unstructured":"Prabakaran P, Gan J, Feng Y, Zhu Z, Choudhry V, Xiao X, Ji X, Dimitrov DS (2006) Structure of severe acute respiratory syndrome coronavirus receptor\u2010binding domain complexed with neutralizing antibody. J Biol Chem 281: 15829\u201315836","journal-title":"J Biol Chem"},{"key":"BFEMMM202114544_CR49","doi-asserted-by":"crossref","first-page":"eabc8413","DOI":"10.1126\/sciimmunol.abc8413","volume":"5","author":"L Premkumar","year":"2020","unstructured":"Premkumar L, Segovia\u2010Chumbez B, Jadi R, Martinez DR, Raut R, Markmann AJ, Cornaby C, Bartelt L, Weiss S, Park Y et\u2009al (2020) The receptor\u2010binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS\u2010CoV\u20102 patients. Science Immunol 5: eabc8413","journal-title":"Science Immunol"},{"key":"BFEMMM202114544_CR50","unstructured":"PyMOL (2015). The PyMOL Molecular Graphics System, Version 2.0 Schr\u00f6dinger, LLC. (Schr\u00f6dinger)"},{"key":"BFEMMM202114544_CR51","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","volume":"584","author":"DF Robbiani","year":"2020","unstructured":"Robbiani DF, Gaebler C, Muecksch F, Lorenzi JCC, Wang Z, Cho A, Agudelo M, Barnes CO, Gazumyan A, Finkin S et\u2009al (2020) Convergent antibody responses to SARS\u2010CoV\u20102 in convalescent individuals. Nature 584: 437\u2013442","journal-title":"Nature"},{"key":"BFEMMM202114544_CR52","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1126\/science.abb7314","volume":"368","author":"B Rockx","year":"2020","unstructured":"Rockx B, Kuiken T, Herfst S, Bestebroer T, Lamers MM, Oude Munnink BB, de Meulder D, van Amerongen G, van den Brand J, Okba NMA et\u2009al (2020) Comparative pathogenesis of COVID\u201019, MERS, and SARS in a nonhuman primate model. Science 368: 1012\u20131015","journal-title":"Science"},{"key":"BFEMMM202114544_CR53","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.abc7520","volume":"369","author":"TF Rogers","year":"2020","unstructured":"Rogers TF, Zhao F, Huang D, Beutler N, Burns A, He W\u2010T, Limbo O, Smith C, Song G, Woehl J et\u2009al (2020) Isolation of potent SARS\u2010CoV\u20102 neutralizing antibodies and protection from disease in a small animal model. Science 369: 956\u2013963","journal-title":"Science"},{"key":"BFEMMM202114544_CR54","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","volume":"180","author":"SHW Scheres","year":"2012","unstructured":"Scheres SHW (2012) RELION: Implementation of a Bayesian approach to cryo\u2010EM structure determination. J Struct Biol 180: 519\u2013530","journal-title":"J Struct Biol"},{"key":"BFEMMM202114544_CR55","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","volume":"117","author":"J Shang","year":"2020","unstructured":"Shang J, Wan Y, Luo C, Ye G, Geng Q, Auerbach A, Li F (2020) Cell entry mechanisms of SARS\u2010CoV\u20102. Proc Natl Acad Sci USA 117: 11727\u201311734","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMMM202114544_CR56","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","volume":"581","author":"J Shang","year":"2020","unstructured":"Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, Geng Q, Auerbach A, Li F (2020) Structural basis of receptor recognition by SARS\u2010CoV\u20102. Nature 581: 221\u2013224","journal-title":"Nature"},{"key":"BFEMMM202114544_CR57","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","volume":"584","author":"R Shi","year":"2020","unstructured":"Shi R, Shan C, Duan X, Chen Z, Liu P, Song J, Song T, Bi X, Han C, Wu L et\u2009al (2020) A human neutralizing antibody targets the receptor\u2010binding site of SARS\u2010CoV\u20102. Nature 584: 120\u2013124","journal-title":"Nature"},{"key":"BFEMMM202114544_CR58","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.cell.2020.08.012","volume":"182","author":"TN Starr","year":"2020","unstructured":"Starr TN, Greaney AJ, Hilton SK, Ellis D, Crawford KHD, Dingens AS, Navarro MJ, Bowen JE, Tortorici MA, Walls AC et\u2009al (2020) Deep mutational scanning of SARS\u2010CoV\u20102 receptor binding domain reveals constraints on folding and ACE2 binding. Cell 182: 1295\u20131310","journal-title":"Cell"},{"key":"BFEMMM202114544_CR59","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.abf9302","volume":"371","author":"TN Starr","year":"2021","unstructured":"Starr TN, Greaney AJ, Addetia A, Hannon WW, Choudhary MC, Dingens AS, Li JZ, Bloom JD (2021) Prospective mapping of viral mutations that escape antibodies used to treat COVID\u201019. Science 371: 850\u2013854","journal-title":"Science"},{"key":"BFEMMM202114544_CR60","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s41422-020-0387-5","volume":"30","author":"W Tai","year":"2020","unstructured":"Tai W, Zhang X, Drelich A, Shi J, Hsu JC, Luchsinger L, Hillyer CD, Tseng C\u2010TK, Jiang S, Du L (2020). A novel receptor\u2010binding domain (RBD)\u2010based mRNA vaccine against SARS\u2010CoV\u20102. Cell Res 30: 932\u2013935","journal-title":"Cell Res"},{"key":"BFEMMM202114544_CR61","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsb.2006.05.009","volume":"157","author":"G Tang","year":"2007","unstructured":"Tang G, Peng L, Baldwin PR, Mann DS, Jiang W, Rees I, Ludtke SJ (2007) EMAN2: an extensible image processing suite for electron microscopy. J Struct Biol 157: 38\u201346","journal-title":"J Struct Biol"},{"key":"BFEMMM202114544_CR62","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41591-021-01255-3","volume":"27","author":"H Tegally","year":"2021","unstructured":"Tegally H, Wilkinson E, Lessells RJ, Giandhari J, Pillay S, Msomi N, Mlisana K, Bhiman JN, von Gottberg A, Walaza S et\u2009al (2021) Sixteen novel lineages of SARS\u2010CoV\u20102 in South Africa. Nat Med 27: 440\u2013446","journal-title":"Nat Med"},{"key":"BFEMMM202114544_CR63","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.cell.2021.01.037","volume":"184","author":"EC Thomson","year":"2021","unstructured":"Thomson EC, Rosen LE, Shepherd JG, Spreafico R, da Silva FA, Wojcechowskyj JA, Davis C, Piccoli L, Pascall DJ, Dillen J et\u2009al (2021) Circulating SARS\u2010CoV\u20102 spike N439K variants maintain fitness while evading antibody\u2010mediated immunity. Cell 184: 1171\u20131187","journal-title":"Cell"},{"key":"BFEMMM202114544_CR64","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jtho.2020.02.010","volume":"15","author":"S Tian","year":"2020","unstructured":"Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY (2020) Pulmonary pathology of early\u2010phase 2019 novel coronavirus (COVID\u201019) pneumonia in two patients with lung cancer. J Thorac Oncol 15: 700\u2013704","journal-title":"J Thorac Oncol"},{"key":"BFEMMM202114544_CR65","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41594-019-0233-y","volume":"26","author":"MA Tortorici","year":"2019","unstructured":"Tortorici MA, Walls AC, Lang Y, Wang C, Li Z, Koerhuis D, Boons G\u2010J, Bosch B\u2010J, Rey FA, de Groot RJ et\u2009al (2019) Structural basis for human coronavirus attachment to sialic acid receptors. Nat Struct Mol Biol 26: 481\u2013489","journal-title":"Nat Struct Mol Biol"},{"key":"BFEMMM202114544_CR66","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.cell.2020.10.043","volume":"183","author":"AC Walls","year":"2020","unstructured":"Walls AC, Fiala B, Sch\u00e4fer A, Wrenn S, Pham MN, Murphy M, Tse LV, Shehata L, O\u2019Connor MA, Chen C et\u2009al (2020) Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS\u2010CoV\u20102. Cell 183: 1367\u20131382","journal-title":"Cell"},{"key":"BFEMMM202114544_CR67","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls AC, Park Y\u2010J, Tortorici MA, Wall A, McGuire AT, Veesler D (2020) Structure, function, and antigenicity of the SARS\u2010CoV\u20102 spike glycoprotein. Cell 181: 281\u2013292","journal-title":"Cell"},{"key":"BFEMMM202114544_CR68","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","volume":"593","author":"P Wang","year":"2021","unstructured":"Wang P, Nair MS, Liu L, Iketani S, Luo Y, Guo Y, Wang M, Yu J, Zhang B, Kwong PD et\u2009al (2021) Antibody resistance of SARS\u2010CoV\u20102 variants B.1.351 and B.1.1.7. Nature 593: 130\u2013135","journal-title":"Nature"},{"key":"BFEMMM202114544_CR69","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","volume":"181","author":"Q Wang","year":"2020","unstructured":"Wang Q, Zhang Y, Wu L, Niu S, Song C, Zhang Z, Lu G, Qiao C, Hu Y, Yuen K\u2010Y et\u2009al (2020) Structural and functional basis of SARS\u2010CoV\u20102 entry by using human ACE2. Cell 181: 894\u2013904","journal-title":"Cell"},{"key":"BFEMMM202114544_CR70","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C\u2010L, Abiona O, Graham BS, McLellan JS (2020) Cryo\u2010EM structure of the 2019\u2010nCoV spike in the prefusion conformation. Science 367: 1260\u20131263","journal-title":"Science"},{"key":"BFEMMM202114544_CR71","volume":"16","author":"NC Wu","year":"2020","unstructured":"Wu NC, Yuan M, Bangaru S, Huang D, Zhu X, Lee C\u2010C, Turner HL, Peng L, Yang L, Burton DR et\u2009al (2020a) A natural mutation between SARS\u2010CoV\u20102 and SARS\u2010CoV determines neutralization by a cross\u2010reactive antibody. PLoS Pathog 16: e1009089","journal-title":"PLoS Pathog"},{"key":"BFEMMM202114544_CR72","doi-asserted-by":"crossref","first-page":"108274","DOI":"10.1016\/j.celrep.2020.108274","volume":"33","author":"NC Wu","year":"2020","unstructured":"Wu NC, Yuan M, Liu H, Lee C\u2010C, Zhu X, Bangaru S, Torres JL, Caniels TG, Brouwer PJM, van Gils MJ et\u2009al (2020b) An alternative binding mode of IGHV3\u201053 antibodies to the SARS\u2010CoV\u20102 receptor binding domain. Cell Rep 33: 108274","journal-title":"Cell Rep"},{"key":"BFEMMM202114544_CR73","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1126\/science.abc2241","volume":"368","author":"Y Wu","year":"2020","unstructured":"Wu Y, Wang F, Shen C, Peng W, Li D, Zhao C, Li Z, Li S, Bi Y, Yang Y et\u2009al (2020) A noncompeting pair of human neutralizing antibodies block COVID\u201019 virus binding to its receptor ACE2. Science 368: 1274\u20131278","journal-title":"Science"},{"key":"BFEMMM202114544_CR74","volume":"7","author":"C Xu","year":"2020","unstructured":"Xu C, Wang Y, Liu C, Zhang C, Han W, Hong X, Wang Y, Hong Q, Wang S, Zhao Q et\u2009al (2020) Conformational dynamics of SARS\u2010CoV\u20102 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo\u2010EM. Sci Adv 7: eabe5575","journal-title":"Sci Adv"},{"key":"BFEMMM202114544_CR75","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q (2020) Structural basis for the recognition of SARS\u2010CoV\u20102 by full\u2010length human ACE2. Science 367: 1444\u20131448","journal-title":"Science"},{"key":"BFEMMM202114544_CR76","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-020-2599-8","volume":"586","author":"J Yang","year":"2020","unstructured":"Yang J, Wang W, Chen Z, Lu S, Yang F, Bi Z, Bao L, Mo F, Li X, Huang Y et\u2009al (2020) A vaccine targeting the RBD of the S protein of SARS\u2010CoV\u20102 induces protective immunity. Nature 586: 572\u2013577","journal-title":"Nature"},{"key":"BFEMMM202114544_CR77","volume":"17","author":"H Yao","year":"2021","unstructured":"Yao H, Cai H, Li T, Zhou B, Qin W, Lavillette D, Li D (2021) A high\u2010affinity RBD\u2010targeting nanobody improves fusion partner\u2019s potency against SARS\u2010CoV\u20102. PLoS Pathog 17: e1009328","journal-title":"PLoS Pathog"},{"key":"BFEMMM202114544_CR78","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.abb7269","volume":"368","author":"M Yuan","year":"2020","unstructured":"Yuan M, Wu NC, Zhu X, Lee C\u2010CD, So RTY, Lv H, Mok CKP, Wilson IA (2020) A highly conserved cryptic epitope in the receptor binding domains of SARS\u2010CoV\u20102 and SARS\u2010CoV. Science 368: 630\u2013633","journal-title":"Science"},{"key":"BFEMMM202114544_CR79","doi-asserted-by":"crossref","first-page":"15092","DOI":"10.1038\/ncomms15092","volume":"8","author":"Y Yuan","year":"2017","unstructured":"Yuan Y, Cao D, Zhang Y, Ma J, Qi J, Wang Q, Lu G, Wu Y, Yan J, Shi Y et\u2009al (2017) Cryo\u2010EM structures of MERS\u2010CoV and SARS\u2010CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat Commun 8: 15092","journal-title":"Nat Commun"},{"key":"BFEMMM202114544_CR80","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/s41594-020-0480-y","volume":"27","author":"D Zhou","year":"2020","unstructured":"Zhou D, Duyvesteyn HME, Chen C\u2010P, Huang C\u2010G, Chen T\u2010H, Shih S\u2010R, Lin Y\u2010C, Cheng C\u2010Y, Cheng S\u2010H, Huang Y\u2010C et\u2009al (2020) Structural basis for the neutralization of SARS\u2010CoV\u20102 by an antibody from a convalescent patient. Nat Struct Mol Biol 27: 950\u2013958","journal-title":"Nat Struct Mol Biol"},{"key":"BFEMMM202114544_CR81","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34317","volume":"7","author":"I Zimmermann","year":"2018","unstructured":"Zimmermann I, Egloff P, Hutter CAJ, Arnold FM, Stohler P, Bocquet N, Hug MN, Huber S, Siegrist M, Hetemann L et\u2009al (2018) Synthetic single domain antibodies for the conformational trapping of membrane proteins. Elife 7: e34317","journal-title":"Elife"},{"key":"BFEMMM202114544_CR82","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/s41596-020-0304-x","volume":"15","author":"I Zimmermann","year":"2020","unstructured":"Zimmermann I, Egloff P, Hutter CAJ, Kuhn BT, Br\u00e4uer P, Newstead S, Dawson RJP, Geertsma ER, Seeger MA (2020) Generation of synthetic nanobodies against delicate proteins. Nat Protoc 15: 1707\u20131741","journal-title":"Nat Protoc"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.202114544.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/emmm.202114544","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/emmm.202114544\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/emmm.202114544","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.202114544.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:37:21Z","timestamp":1779086241000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/emmm.202114544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":82,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,7]]}},"alternative-id":["BFEMMM202114544"],"URL":"https:\/\/doi.org\/10.15252\/emmm.202114544","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,17]]},"assertion":[{"value":"12 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A patent application for monoclonal antibody therapy for the treatment of COVID\u201019 has been filed for FD20 with application No. 202011407906.7 (China National Intellectual Property Administration).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"EMMM202114544"}}